-
biomarkers with CRISPR-Cas13. This technology is ultra-sensative and may revolutionize ‘point of care ‘cancer diagnostics. You will work with state-of-the-art sequencing technologies to profile blood samples
-
: environmental science / imaging / a technical science / robotics / electrical engineering / mechatronics / data science. Next to this, you also have experience with applied research as well as with grant
-
pivotal for optimal patient management. The current diagnostic laboratory procedure and algorithm for classification has limitations that can be overcome with fast Nanopore-sequence technology and deep
-
& technology studies, system innovation, and other related sciences with interest/differentiation/experience in societal engagement and research, science communication, citizen science, inter/transdisciplinarity